Ken Griffin Prokidney Corp Ord Shs Cl A(Cy Transaction History

Citadel Advisors LLC

  • $559 Billion
  • Q4 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Prokidney Corp Ord Shs Cl A(Cy stock. As of the latest transaction made, Citadel Advisors LLC holds 16,400 shares of PROK stock, worth $24,600. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,400
Previous 62,300 73.68%
Holding current value
$24,600
Previous $119,000 77.31%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$1.46 - $2.15 $477 - $703
327 New
327 $0
Q1 2024

May 15, 2024
SELL
$1.2 - $1.76 $10,224 - $14,995
-8,520 Reduced 58.29%
6,096 $9,000
Q4 2023

Feb 14, 2024
BUY
$1.21 - $4.76 $17,685 - $69,572
14,616 New
14,616 $26,000
Q2 2023

Aug 14, 2023
BUY
$9.0 - $13.0 $8,100 - $11,700
900 New
900 $10,000

Others Institutions Holding PROK

# of Institutions
74
Shares Held
47.5M
Call Options Held
100K
Put Options Held
16.4K
View Full List

About PROKIDNEY CORP ORD SHS CL A(CY

PROK Quotes by TradingView
  • Ticker PROK
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,540,200
  • Market Cap $92.3M
More about PROK
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email